Gundersen Health System   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: La Crosse WI United States (1902)

Organization Overview

First Clinical Trial
2003
NCT00083161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Gundersen Health System | Gundersen Lutheran Center for Cancer and Blood | Gundersen Lutheran Health System | Gundersen Lutheran Medical Center | Gundersen Lutheran Medical Foundation | Gunderson Lutheran - LaCrosse

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Lung Neoplasms (Phase 2)

Melanoma (Phase 2)

Pancreatic Diseases (Phase 3)

Pancreatic Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 2)

Ureteral Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8